The IL−17 signaling transduction regulated the infiltration of CD8+ T cells and PD-1/PD-L1 in BRCA patients (Shuai et al., 2020), while the PPAR signaling pathway was activated in TNBC patients (Lin et al., 2021). Here, IL17A is linked to invasive breast carcinoma.